Conceivably, increased nNOS–CAPON interaction mediated the dysfunction of neurons in the Alzheimer's disease model mice, and the nNOS–CAPON interaction may be a new target for developing drugs to treat Alzheimer's disease. Here, NOS1AP is linked to early-onset autosomal dominant Alzheimer disease.